[go: up one dir, main page]

FI955310L - Pharmaceutical composition for oral administration of flavonoids - Google Patents

Pharmaceutical composition for oral administration of flavonoids Download PDF

Info

Publication number
FI955310L
FI955310L FI955310A FI955310A FI955310L FI 955310 L FI955310 L FI 955310L FI 955310 A FI955310 A FI 955310A FI 955310 A FI955310 A FI 955310A FI 955310 L FI955310 L FI 955310L
Authority
FI
Finland
Prior art keywords
flavonoids
pharmaceutical composition
oral administration
oral
administration
Prior art date
Application number
FI955310A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI117123B (en
FI955310A0 (en
Inventor
De Barochez Bruno Huet
Noel Piot
Alain Cuine
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of FI955310A0 publication Critical patent/FI955310A0/en
Publication of FI955310L publication Critical patent/FI955310L/en
Application granted granted Critical
Publication of FI117123B publication Critical patent/FI117123B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
FI955310A 1994-11-08 1995-11-06 Pharmaceutical composition for oral administration of flavonoids FI117123B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9413336 1994-11-08
FR9413336A FR2726469B1 (en) 1994-11-08 1994-11-08 PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF FLAVONOIDS

Publications (3)

Publication Number Publication Date
FI955310A0 FI955310A0 (en) 1995-11-06
FI955310L true FI955310L (en) 1996-05-09
FI117123B FI117123B (en) 2006-06-30

Family

ID=9468588

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955310A FI117123B (en) 1994-11-08 1995-11-06 Pharmaceutical composition for oral administration of flavonoids

Country Status (18)

Country Link
EP (1) EP0711560B1 (en)
JP (1) JP3022952B2 (en)
KR (1) KR960016901A (en)
CN (1) CN1131538A (en)
AT (1) ATE202480T1 (en)
AU (1) AU706027B2 (en)
CA (1) CA2162299C (en)
CY (1) CY2265B1 (en)
DE (1) DE69521477T2 (en)
DK (1) DK0711560T3 (en)
ES (1) ES2160145T3 (en)
FI (1) FI117123B (en)
FR (1) FR2726469B1 (en)
GR (1) GR3036244T3 (en)
NO (1) NO311402B1 (en)
NZ (1) NZ280418A (en)
PT (1) PT711560E (en)
ZA (1) ZA959473B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011151A3 (en) * 1997-05-13 1999-05-04 Jose Remacle Use of a pharmaceutical composition for treating and / or preventing ischemia.
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
JP4273277B2 (en) * 1999-06-30 2009-06-03 大塚製薬株式会社 Oligosaccharide supplement composition
JP2001158796A (en) * 1999-11-30 2001-06-12 Toyo Seito Kk Method for producing alpha-glucosyldiosmin and flavonoid composition
FR2845597B1 (en) * 2002-10-11 2005-03-11 Innothera Lab Sa DRY ORAL FORMULATION CONTAINING DIOSMINE AS A PHARMACEUTICAL FORM OF A TABLET TO BE CROQUERED
PL375621A1 (en) 2002-10-24 2005-12-12 Immupharm A/S Pharmaceutical compositions comprising flavonoids and menthol
AT501682A1 (en) 2005-01-14 2006-10-15 Hermine Dr Engl METHOD FOR PRODUCING AN ACTIVE SUBSTANCE MIXTURE
ITMI20050517A1 (en) 2005-03-30 2006-09-30 Therapicon Srl PHARMACEUTICAL COMPOSITION OF A TYPICAL MICROCRYSTALLINE FRACTION OF FLAVONOIDS
ITMI20051942A1 (en) * 2005-10-14 2007-04-15 S I I T S R L Servizio Interna GALATTOGENIC COMPOSITIONS BASED ON SILIMARINE
WO2007062415A1 (en) * 2005-11-26 2007-05-31 Grinrx Corporeal delivery of carotenoids
MX2007011002A (en) * 2007-09-07 2009-03-09 World Trade Imp Export Wtie Ag Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency.
MX2012001568A (en) * 2009-08-10 2012-04-02 Stokely Van Camp Inc Method for suspending a flavonoid in a beverage.
MD3987C2 (en) * 2009-09-03 2010-07-31 Георге АНГЕЛИЧ Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency
MD3986C2 (en) * 2009-09-23 2010-07-31 Георге АНГЕЛИЧ Use of Diosmine for the treatment of portal gastropathies in the hepatic cirrhosis
MD4231C1 (en) * 2012-11-08 2014-01-31 Георге АНГЕЛИЧ Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis
MD4232C1 (en) * 2012-11-08 2014-01-31 Георге АНГЕЛИЧ Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure
FR2999934B1 (en) * 2012-12-21 2015-02-20 Servier Lab PHARMACEUTICAL COMPOSITION IN THE FORM OF AN ORAL SUSPENSION COMPRISING A FLAVONOIC FRACTION AND XANTHAN GUM
BR112017005362A2 (en) 2014-09-17 2018-01-23 Steerlife India Private Ltd composition, oral solid dosage form, process for preparing porous effervescent granules, dual screw processor, and porous effervescent granules.
US11219594B2 (en) 2015-12-12 2022-01-11 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
FR3083980B1 (en) 2018-07-20 2021-04-16 Servier Lab PHARMACEUTICAL COMPOSITION IN THE FORM OF A CHEWABLE TABLET OF DIOSMINE OR A FLAVONOIC FRACTION
US11304968B2 (en) 2018-11-16 2022-04-19 Janssen Pharmaceutica Nv Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide
US10639294B2 (en) 2018-10-02 2020-05-05 Janssen Pharmaceutica Nv Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide metabolite
WO2021123341A1 (en) 2019-12-20 2021-06-24 Krka, D.D., Novo Mesto Composition comprising diosmin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6967M (en) * 1968-01-22 1969-05-19
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
RO81345B1 (en) * 1980-07-28 1983-02-28 Nicolae Oita Medicament for peripheral cardiovascular insufficiency
AU575930B2 (en) * 1984-03-01 1988-08-11 Hamilton Laboratories Pty. Ltd. Treatment of high protein oedemas in animals
FR2577437A1 (en) * 1985-02-21 1986-08-22 Corbiere Jerome New process for dissolving chemical compounds and aqueous preparations thus obtained
IT1201149B (en) * 1987-01-14 1989-01-27 Indena Spa BIOFLAVONOID COMPLEXES WITH PHOSPHOLIPIDS, THEIR PREPARATION, USE AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS
FR2634376B1 (en) * 1988-07-21 1992-04-17 Farmalyoc NOVEL SOLID AND POROUS UNIT FORM COMPRISING MICROPARTICLES AND / OR NANOPARTICLES, AS WELL AS ITS PREPARATION
FR2661610B1 (en) * 1990-05-02 1994-09-30 Rhone Poulenc Sante NOVEL LYOPHILIZED FORM OF DIOSMINE AND ITS PREPARATION.
FR2661830B1 (en) * 1990-05-11 1992-09-04 Corbiere Jerome NOVEL PHARMACEUTICAL COMPOSITIONS BASED ON FLAVONOSIDE.
FR2668705A1 (en) * 1990-11-06 1992-05-07 Bouchara Sa Novel skin preparations having a phlebotonic action and process for preparing them

Also Published As

Publication number Publication date
GR3036244T3 (en) 2001-10-31
PT711560E (en) 2001-10-30
NO954455L (en) 1996-05-09
FR2726469B1 (en) 1996-12-13
DE69521477T2 (en) 2002-04-18
ATE202480T1 (en) 2001-07-15
AU3669595A (en) 1996-05-16
CA2162299C (en) 2008-09-09
CN1131538A (en) 1996-09-25
KR960016901A (en) 1996-06-17
DK0711560T3 (en) 2001-09-03
JPH08208469A (en) 1996-08-13
AU706027B2 (en) 1999-06-10
ZA959473B (en) 1996-05-15
NZ280418A (en) 1997-03-24
JP3022952B2 (en) 2000-03-21
FI117123B (en) 2006-06-30
FI955310A0 (en) 1995-11-06
NO954455D0 (en) 1995-11-07
CY2265B1 (en) 2003-07-04
EP0711560A1 (en) 1996-05-15
FR2726469A1 (en) 1996-05-10
ES2160145T3 (en) 2001-11-01
DE69521477D1 (en) 2001-08-02
NO311402B1 (en) 2001-11-26
EP0711560B1 (en) 2001-06-27
CA2162299A1 (en) 1996-05-09

Similar Documents

Publication Publication Date Title
FI955310L (en) Pharmaceutical composition for oral administration of flavonoids
ATE284695T1 (en) ORAL MEDICINAL COMPOSITION CONTAINING 2-METHYL-THIENOBENZODIAZEPINE
FI963984L (en) New oral pharmaceutical dosage form
IL115097A0 (en) Pharmaceutical compositions adapted for oral administration
EE04578B1 (en) Pharmaceutical composition for oral administration of the N-piperidino-3-pyrazolecarboxamide derivative, its salts and their solvates
BR9602759A (en) Organoleptically acceptable oral pharmaceutical composition
EE200000395A (en) Oral pharmaceutical pulsatile dosage form
NO20002851D0 (en) Compositions for nasal administration of drugs
ITMI950529A0 (en) PHARMACEUTICAL COMPOSITIONS AND PROCEDURE FOR THEIR PREPARATION
FI950947L (en) Orally administered pharmaceutical formulations
FI953515L (en) Pharmaceutical formulations of fluoxetine
EE200000383A (en) Oral pharmaceutical extended release dosage form
DK0936913T4 (en) ORAL PHARMACEUTICAL PREPARATION CONTAINING IBANDRONATE
DE69822172D1 (en) LEVOSIMENT-CONTAINING ORAL MEDICINAL COMPOSITIONS
FI963679L (en) Stabilized composition for oral administration of peptides
PT862915E (en) ANTIBACTERIAL COMPOSITION FOR ORAL ADMINISTRATION
BR9602758A (en) Organoleptically acceptable oral pharmaceutical composition
FI951357L (en) Pharmaceutical compositions that allow for sustained release of trimetazidine after oral administration
ITMI921123A0 (en) ORAL PHARMACEUTICAL FORMULATIONS CONTAINING ANTHOCYANOSIDS
EE200200075A (en) Pharmaceutical compositions for oral and topical administration
NO950134D0 (en) Formulations for orally administered pharmaceutical agents
EE9900206A (en) Pharmaceutical compositions containing N-sulfonylindoline derivatives
ITMI941169A0 (en) PHARMACEUTICAL FORMULATIONS
ITMI932014A0 (en) EFFERVESCENT ORAL PHARMACEUTICAL COMPOSITIONS CONTAINING ESTRONE
EP0953359A4 (en) Pharmaceutical composition for oral administration

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117123

Country of ref document: FI

MM Patent lapsed